Andrew Bellinger

Andrew Bellinger

Chief Tech/Sci/R&D Officer at VERVE THERAPEUTICS, INC.

Net worth: 566 113 $ as of 2024-03-30

Consumer Services
Health Technology
Technology Services

Profile

Andrew Bellinger was the founder of Lyndra Therapeutics, Inc. (founded in 2015) and held the title of Chief Scientific Officer.
Dr. Bellinger is also the founder of Corner Therapeutics, Inc. Dr. Bellinger's current job is as the Chief Scientific Officer at Verve Therapeutics, Inc. (since 2019).
Dr. Bellinger's former job was as the Chief Scientific Officer at Cocoon Biotech, Inc. Dr. Bellinger's education includes a doctorate from The Trustees of Columbia University in The City of New York, a graduate degree from New York University, and an undergraduate degree from Princeton University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-13 42,629 ( 0.05% ) 566 113 $ 2024-03-30

Andrew Bellinger active positions

CompaniesPositionStart
VERVE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2019-09-30
Corner Therapeutics Founder -
All active positions of Andrew Bellinger

Former positions of Andrew Bellinger

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer -
Founder -
See the detail of Andrew Bellinger's experience

Training of Andrew Bellinger

The Trustees of Columbia University in The City of New York Doctorate Degree
New York University Graduate Degree
Princeton University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Bellinger's experience

Connections

31

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
VERVE THERAPEUTICS, INC.

Health Technology

Private companies3

Health Technology

Technology Services

Corner Therapeutics

Technology Services

See company connections
  1. Stock Market
  2. Insiders
  3. Andrew Bellinger